1 January–31 December
|
kEUR |
2025 |
2024 |
|
|
|
|
|
|
|
Result for the year |
|
-21,169 |
-19,564 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
-333 |
-523 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
-333 |
-523 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
4,245 |
-6,490 |
|
|
Income tax effect |
-927 |
1,392 |
|
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
3,318 |
-5,098 |
|
Other comprehensive result for the year, net of taxes |
|
2,985 |
-5,621 |
|
|
|
|
|
|
Total comprehensive result for the year, net of taxes |
|
-18,184 |
-25,185 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
-18,184 |
-25,185 |